352 related articles for article (PubMed ID: 24794151)
1. Aiming for SDAI remission versus low disease activity at 1 year after inclusion in ESPOIR cohort is associated with better 3-year structural outcomes.
Ruyssen-Witrand A; Guernec G; Nigon D; Tobon G; Jamard B; Rat AC; Vittecoq O; Cantagrel A; Constantin A
Ann Rheum Dis; 2015 Sep; 74(9):1676-83. PubMed ID: 24794151
[TBL] [Abstract][Full Text] [Related]
2. Routine Assessment of Patient Index Data 3 and the American College of Rheumatology/European League Against Rheumatism Provisional Remission Definitions as Predictors of Radiographic Outcome in a Rheumatoid Arthritis Clinical Trial With Tocilizumab.
Khawaja MN; Bergman MJ; Yourish J; Pei J; Reiss W; Keystone E
Arthritis Care Res (Hoboken); 2017 May; 69(5):609-615. PubMed ID: 27564431
[TBL] [Abstract][Full Text] [Related]
3. Ten-year radiographic and functional outcomes in rheumatoid arthritis patients in remission compared to patients in low disease activity.
Ruyssen-Witrand A; Guernec G; Dupont J; Lapuyade D; Lioté F; Vittecoq O; Degboé Y; Constantin A
Arthritis Res Ther; 2023 Oct; 25(1):207. PubMed ID: 37864239
[TBL] [Abstract][Full Text] [Related]
4. Structural damages disturb functional improvement in patients with rheumatoid arthritis treated with etanercept.
Tanaka Y; Yamanaka H; Saito K; Iwata S; Miyagawa I; Seto Y; Momohara S; Nagasawa H; Kameda H; Kaneko Y; Izumi K; Amano K; Takeuchi T
Mod Rheumatol; 2012 Apr; 22(2):186-94. PubMed ID: 21901357
[TBL] [Abstract][Full Text] [Related]
5. Achieving simplified disease activity index remission in patients with active rheumatoid arthritis is associated with subsequent good functional and structural outcomes in a real-world clinical setting under a treat-to-target strategy.
Hirano F; Yokoyama W; Yamazaki H; Amano K; Kawakami A; Hayashi T; Tamura N; Yasuda S; Dobashi H; Fujii T; Ito S; Kaneko Y; Matsui T; Okuda Y; Saito K; Suzuki F; Yoshimi R; Sakai R; Koike R; Kohsaka H; Miyasaka N; Harigai M;
Mod Rheumatol; 2017 Sep; 27(5):811-819. PubMed ID: 27919205
[TBL] [Abstract][Full Text] [Related]
6. Remission in early rheumatoid arthritis defined by 28 joint counts: limited consequences of residual disease activity in the forefeet on outcome.
van Tuyl LH; Britsemmer K; Wells GA; Smolen JS; Zhang B; Funovits J; van Schaardenburg D; Felson D; Boers M
Ann Rheum Dis; 2012 Jan; 71(1):33-7. PubMed ID: 21953347
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the preliminary definitions of minimal disease activity and remission in an early seropositive rheumatoid arthritis cohort.
Khanna D; Oh M; Furst DE; Ranganath V; Gold RH; Sharp JT; Park GS; Keystone EC; Paulus HE;
Arthritis Rheum; 2007 Apr; 57(3):440-7. PubMed ID: 17394230
[TBL] [Abstract][Full Text] [Related]
8. Comparison of physical function in early rheumatoid arthritis patients treated with biologics for 1 year who achieved clinical remission or low disease activity.
Hattori Y; Kida D; Kaneko A
Clin Rheumatol; 2017 Nov; 36(11):2607-2612. PubMed ID: 28823077
[TBL] [Abstract][Full Text] [Related]
9. Clinical, radiographic and functional efficacy of abatacept in routine care for rheumatoid arthritis patients: Abatacept Leading Trial for RA on Imaging Remission (ALTAIR) study.
Kubo S; Nakano K; Nakayamada S; Hirata S; Fukuyo S; Sawamukai N; Saito K; Tanaka Y
Clin Exp Rheumatol; 2016; 34(5):834-841. PubMed ID: 27607196
[TBL] [Abstract][Full Text] [Related]
10. Five-year favorable outcome of patients with early rheumatoid arthritis in the 2000s: data from the ESPOIR cohort.
Combe B; Rincheval N; Benessiano J; Berenbaum F; Cantagrel A; Daurès JP; Dougados M; Fardellone P; Fautrel B; Flipo RM; Goupille P; Guillemin F; Le Loët X; Logeart I; Mariette X; Meyer O; Ravaud P; Saraux A; Schaeverbeke T; Sibilia J
J Rheumatol; 2013 Oct; 40(10):1650-7. PubMed ID: 23950185
[TBL] [Abstract][Full Text] [Related]
11. Simplified Disease Activity Index remission at month 6 is an independent predictor of functional and structural remissions at month 12 during abatacept treatment in patients with rheumatoid arthritis: A multi-center, prospective cohort study in Japan.
Yamazaki H; Hirano F; Takeuchi T; Amano K; Kikuchi J; Kihara M; Yokoyama W; Sugihara T; Nagasaka K; Hagiyama H; Nonomura Y; Sakai R; Tanaka M; Koike R; Nanki T; Kohsaka H; Miyasaka N; Harigai M
Mod Rheumatol; 2017 Sep; 27(5):787-794. PubMed ID: 27846756
[TBL] [Abstract][Full Text] [Related]
12. How much does Disease Activity Score in 28 joints ESR and CRP calculations underestimate disease activity compared with the Simplified Disease Activity Index?
Fleischmann R; van der Heijde D; Koenig AS; Pedersen R; Szumski A; Marshall L; Bananis E
Ann Rheum Dis; 2015 Jun; 74(6):1132-7. PubMed ID: 25143522
[TBL] [Abstract][Full Text] [Related]
13. Structural and functional outcomes of a therapeutic strategy targeting low disease activity in patients with elderly-onset rheumatoid arthritis: a prospective cohort study (CRANE).
Sugihara T; Ishizaki T; Hosoya T; Iga S; Yokoyama W; Hirano F; Miyasaka N; Harigai M
Rheumatology (Oxford); 2015 May; 54(5):798-807. PubMed ID: 25296748
[TBL] [Abstract][Full Text] [Related]
14. 'Insights in the relationship of joint space narrowing versus erosive joint damage and physical functioning of patients with RA'.
Koevoets R; Dirven L; Klarenbeek NB; van Krugten MV; Ronday HK; van der Heijde DM; Huizinga TW; Kerstens PS; Lems WF; Allaart CF
Ann Rheum Dis; 2013 Jun; 72(6):870-4. PubMed ID: 22753403
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of abatacept in routine care of patients with rheumatoid arthritis: Orencia(®) as Biological Intensive Treatment for RA (ORBIT) study.
Tanaka Y; Kubo S; Yamanaka H; Amano K; Hirata S; Tanaka E; Nagasawa H; Yasuoka H; Takeuchi T
Mod Rheumatol; 2014 Sep; 24(5):754-62. PubMed ID: 25036232
[TBL] [Abstract][Full Text] [Related]
16. Flares in Rheumatoid Arthritis Patients with Low Disease Activity: Predictability and Association with Worse Clinical Outcomes.
Bechman K; Tweehuysen L; Garrood T; Scott DL; Cope AP; Galloway JB; Ma MHY
J Rheumatol; 2018 Nov; 45(11):1515-1521. PubMed ID: 30173149
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the long-term outcome for patients with rheumatoid arthritis with persistent moderate disease activity or disease remission during the first year after diagnosis: data from the ESPOIR cohort.
Combe B; Logeart I; Belkacemi MC; Dadoun S; Schaeverbeke T; Daurès JP; Dougados M
Ann Rheum Dis; 2015 Apr; 74(4):724-9. PubMed ID: 24399234
[TBL] [Abstract][Full Text] [Related]
18. In patients with early rheumatoid arthritis, the new ACR/EULAR definition of remission identifies patients with persistent absence of functional disability and suppression of ultrasonographic synovitis.
Sakellariou G; Scirè CA; Verstappen SM; Montecucco C; Caporali R
Ann Rheum Dis; 2013 Feb; 72(2):245-9. PubMed ID: 23060009
[TBL] [Abstract][Full Text] [Related]
19. Baseline HAQ and SF-36 questionnaire scores cannot predict clinical remission, radiographic progression or the need for biological therapy in a three-year prospective study of a Brazilian early rheumatoid arthritis cohort.
da Mota LM; Dos Santos Neto LL; Oliveira AC; Pereira IA; Burlingame RW; Ménard HA; Laurindo IM
Rheumatol Int; 2012 Dec; 32(12):3937-43. PubMed ID: 22198690
[TBL] [Abstract][Full Text] [Related]
20. Physical function continues to improve when clinical remission is sustained in rheumatoid arthritis patients.
Radner H; Alasti F; Smolen JS; Aletaha D
Arthritis Res Ther; 2015 Aug; 17(1):203. PubMed ID: 26259838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
